Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30799537)

  • 1. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
    Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
    Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
    Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
    Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
    World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
    von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
    J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]   [Full Text] [Related]  

  • 9. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The choice of surgical therapy in adenocarcinoma of the cardia].
    Solerio D; Camandona M; Gasparri G; Casalegno PA; Raggio E; Dei Poli M
    Minerva Chir; 2005 Feb; 60(1):17-22. PubMed ID: 15902049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
    Schuhmacher C; Gretschel S; Lordick F; Reichardt P; Hohenberger W; Eisenberger CF; Haag C; Mauer ME; Hasan B; Welch J; Ott K; Hoelscher A; Schneider PM; Bechstein W; Wilke H; Lutz MP; Nordlinger B; Van Cutsem E; Siewert JR; Schlag PM
    J Clin Oncol; 2010 Dec; 28(35):5210-8. PubMed ID: 21060024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance.
    Zhang X; He XD; Zhang YC; Yang KH; Tian JH; Chen YL
    Medicine (Baltimore); 2021 Sep; 100(35):e27106. PubMed ID: 34477150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the efficacy of different surgical strategies in the treatment of patients with initially resectable gastric cancer liver metastases].
    Li L; Gao YH; Zang L; Xue K; Ke B; Shang L; Tang ZQ; Yu J; Liang YR; He ZR; Zheng HL; Huang H; Xiong JP; He ZY; Li JY; Lu TT; Song QY; Liu SH; Chen YW; Tang Y; Liang H; Qiao Z; Chen L
    Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):370-378. PubMed ID: 38548604
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of the preoperative inflammation-based prognostic score and the ratio of visceral fat area to psoas muscle area on predicting survival for surgically resected adenocarcinoma of the esophagogastric junction.
    Uchida S; Sohda M; Tateno K; Watanabe T; Shibasaki Y; Nakazawa N; Kuriyama K; Sano A; Yokobori T; Sakai M; Ogawa H; Shirabe K; Saeki H
    Esophagus; 2024 Apr; 21(2):157-164. PubMed ID: 38112929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal junction adenocarcinoma.
    Swisher SG; Pisters PW; Komaki R; Lahoti S; Ajani JA
    Curr Treat Options Oncol; 2000 Dec; 1(5):387-98. PubMed ID: 12057146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the length of proximal margin on the prognosis in adenocarcinoma of gastroesophageal junction: A real-world study and strategies.
    Pang T; Nie MM; Fan L; Wang JY; Liu ZR; Qin Y; Yin K
    Asian J Surg; 2024 Jun; 47(6):2613-2622. PubMed ID: 38565445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction.
    Mueller JD; Stein HJ; Oyang T; Natsugoe S; Feith M; Werner M; Rüdiger Siewert J
    Cancer; 2000 Nov; 89(9):1874-82. PubMed ID: 11064343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in clinicopathology of oesophagogastric adenocarcinoma: a single-centre longitudinal study of 347 cases over a 20-year period.
    Huang Q; Lew E; Cheng Y; Huang K; Deshpande V; Shinagare S; Yuan X; Gold JS; Wiener D; Weber HC
    Pathology; 2024 Jun; 56(4):484-492. PubMed ID: 38480051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].
    Zhao AG; Cao W; Xu Y; Zhao G; Liu BY; Cai Y; Yang JZ; Gu Y; Yuan W; Zhu YJ; Han YY; Yang JY
    Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):224-30. PubMed ID: 20226143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single-institution retrospective analysis of 2163 Chinese patients.
    Liu X; Qiu H; Huang Y; Xu D; Li W; Li Y; Chen Y; Zhou Z; Sun X
    Cancer Med; 2018 Feb; 7(2):360-369. PubMed ID: 29341506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.